Define range intervals using parentheses.
E.g. C7H(10-14)O(0-4)

to
±
(example: 123 ± 1)

to
±

to
±
 

to
±
 
Search Hits Limit:
Single/Multi-component
Isotopically Labeled
Additional Filters

Found 510 results

Search term: MF = 'C_{29}H_{31}ClN_{4}O_{2}'
12345
IDStructureMolecular FormulaMolecular Weight# of Data Sources# of References# of PubMed# of RSC
7877425

Double-bond stereo
InChI=1/C29H31ClN4O2/c1-29(2,3)22-14-10-21(11-15-22)19-31-33-28(36)26(18-20-12-16-23(17-13-20)34(4)5)32-27(35)24-8-6-7-9-25(24)30/h6-19H,1-5H3,(H,32,35)(H,33,36)/b26-18-,31-19+
C29H31ClN4O2503.035181500
4480520
InChI=1/C29H31ClN4O2/c1-19-11-12-20(30)17-25(19)32-13-15-33(16-14-32)28(35)23-18-34(21-7-3-4-8-21)29(36)27-26(23)22-9-5-6-10-24(22)31(27)2/h5-6,9-12,17-18,21H,3-4,7-8,13-16H2,1-2H3
C29H31ClN4O2503.03510800
21350469

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H30N4O2.ClH/c1-18-11-19(2)13-23(12-18)32-29(35)27(15-22-17-30-25-10-6-5-9-24(22)25)33-28(34)26-14-20-7-3-4-8-21(20)16-31-26;/h3-13,17,26-27,30-31H,14-16H2,1-2H3,(H,32,35)(H,33,34);1H/t26-,27-;/m0./s1
C29H31ClN4O2503.0359500
13121542
InChI=1/C29H31ClN4O2/c1-31-25-13-6-5-12-23(25)26-24(19-34(29(36)27(26)31)21-9-3-2-4-10-21)28(35)33-16-14-32(15-17-33)22-11-7-8-20(30)18-22/h5-8,11-13,18-19,21H,2-4,9-10,14-17H2,1H3
C29H31ClN4O2503.0359700
20251417
InChI=1/C29H31ClN4O2/c1-31-25-10-6-5-9-23(25)26-24(19-34(29(36)27(26)31)22-7-3-2-4-8-22)28(35)33-17-15-32(16-18-33)21-13-11-20(30)12-14-21/h5-6,9-14,19,22H,2-4,7-8,15-18H2,1H3
C29H31ClN4O2503.0359700
21678011
InChI=1/C29H31ClN4O2/c1-4-24(35)28-27(20-11-7-6-8-12-20)22-13-9-10-16-32-25(31-34(28)29(22)32)18-33(26(36)5-2)23-17-21(30)15-14-19(23)3/h6-8,11-12,14-15,17H,4-5,9-10,13,16,18H2,1-3H3
C29H31ClN4O2503.0359600
20266369

1 of 1 defined stereocentres - 1/1 defined
InChI=1/C29H31ClN4O2/c30-24-11-6-12-25(20-24)33-18-16-32(17-19-33)15-7-14-31-28(35)27(22-8-2-1-3-9-22)34-21-23-10-4-5-13-26(23)29(34)36/h1-6,8-13,20,27H,7,14-19,21H2,(H,31,35)/t27-/m1/s1
C29H31ClN4O2503.0358700
20425563
InChI=1/C29H31ClN4O2/c1-20-4-7-22(8-5-20)28-25-18-23(9-11-26(25)32-36-28)29(35)31-12-3-13-33-14-16-34(17-15-33)27-19-24(30)10-6-21(27)2/h4-11,18-19H,3,12-17H2,1-2H3,(H,31,35)
C29H31ClN4O2503.0358700
21350523

2 of 3 defined stereocentres - 2/3 defined
InChI=1/C29H30N4O2.ClH/c1-19(20-9-3-2-4-10-20)32-29(35)27(16-23-18-30-25-14-8-7-13-24(23)25)33-28(34)26-15-21-11-5-6-12-22(21)17-31-26;/h2-14,18-19,26-27,30-31H,15-17H2,1H3,(H,32,35)(H,33,34);1H/t19?,26-,27-;/m0./s1
C29H31ClN4O2503.0358600
2896846

Double-bond stereo
InChI=1/C29H31ClN4O2/c30-26-14-11-23(12-15-26)13-16-27(35)31-32-28(36)17-18-33-19-21-34(22-20-33)29(24-7-3-1-4-8-24)25-9-5-2-6-10-25/h1-16,29H,17-22H2,(H,31,35)(H,32,36)
C29H31ClN4O2503.035048800
29767057

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H30N4O2.ClH/c1-18-11-12-24(19(2)13-18)32-29(35)27(15-22-17-30-25-10-6-5-9-23(22)25)33-28(34)26-14-20-7-3-4-8-21(20)16-31-26;/h3-13,17,26-27,30-31H,14-16H2,1-2H3,(H,32,35)(H,33,34);1H/t26-,27-;/m0./s1
C29H31ClN4O2503.0358500
4735423

Double-bond stereo
InChI=1/C29H31ClN4O2/c30-26-14-11-23(12-15-26)13-16-27(35)31-32-28(36)17-18-33-19-21-34(22-20-33)29(24-7-3-1-4-8-24)25-9-5-2-6-10-25/h1-16,29H,17-22H2,(H,31,35)(H,32,36)/b16-13+
C29H31ClN4O2503.0357300
22615399
InChI=1/C29H31ClN4O2/c1-21-26(20-33(28(35)31-29(2,3)4)19-22-12-7-5-8-13-22)27(36-25-16-9-6-10-17-25)34(32-21)24-15-11-14-23(30)18-24/h5-18H,19-20H2,1-4H3,(H,31,35)
C29H31ClN4O2503.0357600
22649256

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H31ClN4O2/c1-36-28-14-8-6-12-24(28)26-19-27(23-11-5-7-13-25(23)30)34(31-26)29(35)21-33-17-15-32(16-18-33)20-22-9-3-2-4-10-22/h2-14,27H,15-21H2,1H3
C29H31ClN4O2503.0357600
22650299

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H31ClN4O2/c1-36-28-10-6-5-9-25(28)26-19-27(23-11-13-24(30)14-12-23)34(31-26)29(35)21-33-17-15-32(16-18-33)20-22-7-3-2-4-8-22/h2-14,27H,15-21H2,1H3
C29H31ClN4O2503.0357600
22697651

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H31ClN4O2/c1-36-24-13-11-23(12-14-24)28-19-27(25-9-5-6-10-26(25)30)31-34(28)29(35)21-33-17-15-32(16-18-33)20-22-7-3-2-4-8-22/h2-14,28H,15-21H2,1H3
C29H31ClN4O2503.0357600
22697682

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H31ClN4O2/c1-36-28-14-8-6-12-24(28)27-19-26(23-11-5-7-13-25(23)30)31-34(27)29(35)21-33-17-15-32(16-18-33)20-22-9-3-2-4-10-22/h2-14,27H,15-21H2,1H3
C29H31ClN4O2503.0357600
22698290

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H31ClN4O2/c1-36-24-13-11-23(12-14-24)27-19-28(25-9-5-6-10-26(25)30)34(31-27)29(35)21-33-17-15-32(16-18-33)20-22-7-3-2-4-8-22/h2-14,28H,15-21H2,1H3
C29H31ClN4O2503.0357600
22698446

0 of 1 defined stereocentres - 0/1 defined
InChI=1/C29H31ClN4O2/c1-36-26-9-5-8-24(18-26)27-19-28(23-10-12-25(30)13-11-23)34(31-27)29(35)21-33-16-14-32(15-17-33)20-22-6-3-2-4-7-22/h2-13,18,28H,14-17,19-21H2,1H3
C29H31ClN4O2503.0357600
29767011

2 of 2 defined stereocentres - 2/2 defined
InChI=1/C29H30N4O2.ClH/c1-2-19-11-13-23(14-12-19)32-29(35)27(16-22-18-30-25-10-6-5-9-24(22)25)33-28(34)26-15-20-7-3-4-8-21(20)17-31-26;/h3-14,18,26-27,30-31H,2,15-17H2,1H3,(H,32,35)(H,33,34);1H/t26-,27-;/m0./s1
C29H31ClN4O2503.0357500
12345

Advertisement